Desquamative gingivitis: Early presenting symptom of mucocutaneous disease

Quintessence International

Volumn 34, Issue 8, 2003, Pages 582-586

  Stoopler, Eric T ^a   Sollecito, Thomas P ^a   DeRossi, Scott S ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Desquamative gingivitis; Erosive lichen planus; Mucous membrane pemphigoid; Pemphigus vulgaris; Reticular lichen planus

Indexed keywords

AZATHIOPRINE; CLOBETASOL; CORTICOSTEROID; CYCLOPHOSPHAMIDE; DAPSONE; DESMOGLEIN 3; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FIBRINOGEN; FLAVORING AGENT; FLUOCINONIDE; GLUCOSE 6 PHOSPHATE DEHYDROGENASE; IMMUNOGLOBULIN G ANTIBODY; IMMUNOSUPPRESSIVE AGENT; MINOCYCLINE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; NICOTINAMIDE; NONSTEROID ANTIINFLAMMATORY AGENT; PENICILLAMINE; PREDNISONE; STEROID; TETRACYCLINE; TSUKUBAENOLIDE;

ACUTE DISEASE; AUTOIMMUNE DISEASE; BIOPSY; BLISTER; CICATRICIAL PEMPHIGOID; CLINICAL FEATURE; CLINICAL PRACTICE; DESMOSOME; DESQUAMATION; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DISEASE CONTROL; DISEASE COURSE; DISEASE SEVERITY; DRUG MEGADOSE; DRUG POTENCY; DRUG USE; DYSPLASIA; EARLY DIAGNOSIS; ERYTHEMA; ERYTHEMATOUS PEMPHIGUS; GINGIVA; GINGIVITIS; GLUCOSE 6 PHOSPHATE DEHYDROGENASE DEFICIENCY; HEMOLYSIS; HISTOLOGY; HISTOPATHOLOGY; HUMAN; HYPERPIGMENTATION; IMMUNOFLUORESCENCE TEST; IMMUNOLOGICAL PROCEDURES; INCIDENCE; KERATINOCYTE; LICHEN PLANUS; LICHENOID; LOW DRUG DOSE; LYMPHOMA; MOUTH CAVITY; MOUTH HYGIENE; MOUTH ULCER; MUCOSA; NAUSEA; PATIENT EDUCATION; PEMPHIGUS; PEMPHIGUS FOLIACEUS; PHOTOSENSITIVITY; PROPHYLAXIS; REVIEW; SPLINT; SQUAMOUS CELL CARCINOMA; SYMPTOMATOLOGY; SYSTEMIC DISEASE; VERTIGO; VOMITING;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; AUTOIMMUNE DISEASES; BIOPSY; CLOBETASOL; DAPSONE; DIAGNOSIS, DIFFERENTIAL; FLUOCINONIDE; GINGIVITIS; GLUCOCORTICOIDS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LICHEN PLANUS, ORAL; PEMPHIGOID, BENIGN MUCOUS MEMBRANE; PEMPHIGUS; PREDNISONE;

EID: 0141729305     PISSN: 00336572     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (27)

1. Lindhe J, Karring T. The anatomy of the periodontium. In: Lindhe J (ed). Textbook of Clinical Periodontology, ed 2. Copenhagen: Munksgaard, 1989:19-69.
2. Kowitz G, Jacobsen J, Meng Z, Lucatorto F. The effects of tartar-control toothpaste on the oral soft tissues. Oral Surg Oral Med Oral Pathol 1990;70:529-536.
3. Brightman VJ. Red and white lesions of the oral mucosa. In: Lynch MA, Brightman VJ, Greenberg MS (eds). Burket's Oral Medicine, ed 9. Philadelphia: Lippincott-Raven, 1994:51-120.
4. Jungell P. Oral lichen planus. A review. Int J Oral Maxillofac Surg 1991;20:129-135.
5. Wright JM. A review and update of intraoral lichen planus. Texas Dental J 2001;118:450-454.
6. van der Meij EH, van der Waal I. Hepatitis C virus infection and oral lichen planus: A report from the Netherlands. J Oral Pathol and Med 2000;29:255-258.
7. Andreason JO. Oral lichen planus. I. A clinical evaluation of 115 cases. Oral Surg Oral Med Oral Pathol 1968;5:31-42.
8. McClachey KD, Silverman S, Hansen LS. Studies in oral lichen planus. III. Clinical and histological correlations in 213 patients. Oral Surg Oral Med Oral Pathol 1975;39:122-129.
9. Silverman S, Gorsky M, Lozada-Nur F. A prospective follow-up study of 570 patients with oral lichen planus: Persistence, remission, and malignant association. Oral Surg Oral Med Oral Pathol 1985;60:30-34.
10. Vente C, Reich K, Rupprecht R, Neumann C. Erosive mucosal lichen planus: Response to topical treatment with tacrolimus. Br J Dermatol 1999;140:338-342.
11. Lener EV, Brieva J, Schacter M, West L, el-Azhary RA. Successful treatment of erosive lichen planus with topical tacrolimus. Arch Dermatol 2001;137:419-422.
12. Rozycki TW, Rogers III R, Pittelkow MR, et al. Topical tacrolimus in the treatment of symptomatic oral lichen planus: A series of 13 patients. J Am Acad Dermatol 2002;46:27-34.
13. Stoopler ET, Sollecito TP, DeRossi SS. Management of oral lichen planus (olp) resistant to topical corticosteroids [abstract]. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2002;93:425.
14. Williams DM. Vesiculobullous mucocutaneous disease: Pemphigus vulgaris. J Oral Pathol Med 1989;18:544-553.
15. Greenberg MS. Ulcerative, vesicular, and bullous lesions. In: Greenberg MS, Glick M (eds). Burket's Oral Medicine, ed 10. Ontario: BC Decker, 2003:50-84.
16. Greenberg MS. Drugs used for connective-tissue disorders and oral mucosal diseases. In: ADA Guide to Dental Therapeutics. Chicago: American Dental Association, 2000:438-453.
17. Bondesson L, Hammar H. Treatment of pemphigus vulgaris with cyclosporine. Dermatologica 1990;181:308-310.
18. Aberer W, Wolff-Schreiner EC, Stingl G, Wolff K. Azathioprine in the treatment of pemphigus vulgaris. J Am Acad Dermatol 1987;16:527-533.
19. Bohm M, Beissert S, Schwarz T, Metze D, Luger T. Bullous pemphigoid treated with mycophenolate mofetil [letter]. Lancet 1997;349:541.
20. Enk AH, Knop J. Mycophenolate is effective in the treatment of pemphigus vulgaris. Arch Dermatol 1999;135:554-569.
21. Ciarrocca KN, Greenberg MS. A retrospective study of the management of oral mucous membrane pemphigoid with dapsone. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1998;88:159-163.
22. Robinson JC, Lozada-Nur F, Frieden I. Oral pemphigus vulgaris: A review of the literature and a report on the management of 12 cases. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1997;84:349-355.
23. Kim Y, Greenberg MS. Management of patients with severe oral mucosal disease. Alpha Omegan 2001;94:18-23.
24. Rogers RS 3rd, Mehregan DA. Dapsone therapy of cicatricial pemphigoid. Semin Dermatol 1988;7:201-205.
25. Todd P, Samartunga IR, Pembroke A. Screening for glucose-6-phosphatedehydrogenase deficiency prior to dapsone therapy. Clin Experim Derm 1994;19:217-218.
26. Poskitt L, Worjnarowska F. Minimizing cicatricial pemphigoid orodynia with minocycline. Br J Dermatol 1995;132:784-789.
27. Reiche L, Worjnarowska F, Mallon E. Combination therapy with nicotinamide and tetracyclines for cicatricial pemphigoid: Further support for its efficacy. Clin Exp Dermatol 1998;23:254-257.